Replies to post #168597 on Biotech Values

[DewDiligence]

(MNTA)—NVS reports $51M of 4Q13 Lovenox sales, a slight drop from 3Q13 sales of $58M and 2Q13 sales of $57M:

http://www.sec.gov/Archives/edgar/data/1114448/000137036814000004/a140129-99_2.htm

NVS’ total Lovenox sales for 2013 were $213M.